IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NEA Management Company, LLC

Q2 2026 Holdings

Filed 2026-08-14 | 26 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Trevi Therapeutics, Inc.(TRVI)COM89532M101$246.6M13,222,22815.5%
MBX Biosciences, Inc.(MBX)COM55287L101$199.5M3,614,48612.6%
Monte Rosa Therapeutics, Inc.(GLUE)COM61225M102$186.2M7,692,29811.7%
Celcuity Inc.(CELC)COM15102K100$179.0M1,710,56111.3%
Spyglass Pharma, Inc.(SGP)COM SHS85220G109$164.6M7,392,30110.4%
Savara, Inc.(SVRA)COM805111101$150.7M24,471,2649.5%
Zenas BioPharma, Inc.(ZBIO)COM98937L105$102.1M4,023,2196.4%
Coursera, Inc.(COUR)COM22266M104$72.6M12,867,7694.6%
Aurinia Pharmaceuticals, Inc.(AUPH)COM05156V102$67.4M3,969,8344.2%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$57.7M1,058,5703.6%
Oric Pharmaceuticals, Inc.(ORIC)COM68622P109$44.6M4,118,6212.8%
Phathom Pharmaceuticals, Inc.(PHAT)COM71722W107$21.3M1,960,1691.3%
Korro Bio, Inc.(KRRO)COM500946108$17.1M1,297,8931.1%
X4 Pharmaceuticals, Inc.(ASNSUSD)COM98420X103$15.1M3,233,7431.0%
Champions Oncology, Inc.(CSBR)COM NEW15870P307$10.6M1,713,7200.7%
Nkarta, Inc.(NKTX)COM65487U108$10.1M3,568,7810.6%
CVRx, Inc.(CVRX)COM126638105$10.0M1,954,4400.6%
Black Diamond Therapeutics, Inc.(BDTX)COM09203E105$8.2M4,448,7570.5%
Karyopharm Therapeutics Inc.(KPTI)COM NEW48576U205$5.6M576,7800.4%
Inventiva SA(IVA)ADS46124U107$5.5M1,462,5860.3%
LeonaBio, Inc.(LONA)COM04746L203$4.3M464,3980.3%
Senti Biosciences, Inc.(SNTI)COM NEW81726A209$4.2M3,775,6150.3%
Marker Therapeutics, Inc.(MRKR)COM NEW57055L206$2.4M1,625,6780.2%
OnKure Therapeutics, Inc.(OKUR)COM CL A68277Q105$2.2M478,5480.1%
ImageneBio, Inc.(IMA)COM45175G207$295.0K50,0050.0%
Gossamer Bio, Inc.(GOSS)COM38341P102$164.6K1,000,0000.0%